These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6187481)

  • 1. Administration of myelin basic protein-coupled spleen cells prevents experimental allergic encephalitis.
    Sriram S; Schwartz G; Steinman L
    Cell Immunol; 1983 Feb; 75(2):378-82. PubMed ID: 6187481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
    Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
    Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of experimental allergic encephalomyelitis by MBP-coupled lymphoid cells and by MBP-liposomes: a comparison.
    Strejan GH; St Louis J
    Cell Immunol; 1990 May; 127(2):284-98. PubMed ID: 1691689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific immune regulation of chronic-relapsing experimental allergic encephalomyelitis in mice.
    Kennedy MK; Dal Canto MC; Trotter JL; Miller SD
    J Immunol; 1988 Nov; 141(9):2986-93. PubMed ID: 2459237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction.
    Kennedy MK; Tan LJ; Dal Canto MC; Miller SD
    J Immunol; 1990 Jul; 145(1):117-26. PubMed ID: 2358669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of oral myelin basic protein and dexamethasone treatment on experimental autoimmune encephalomyelitis.
    Mokhtarian F; Shirazian T; Batuman O; Shi Y
    Ann N Y Acad Sci; 1996 Feb; 778():414-7. PubMed ID: 8611007
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of experimental allergic encephalomyelitis in Lewis rats treated with myelin basic protein-liposome complexes: clinical, histopathological, and cell-mediated immunity correlates.
    Strejan GH; Percy DH; St Louis J
    Cell Immunol; 1984 Mar; 84(1):171-84. PubMed ID: 6199120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental allergic encephalomyelitis (EAE) in mice. I. Induction of EAE with mouse spinal cord homogenate and myelin basic protein.
    Yasuda T; Tsumita T; Nagai Y; Mitsuzawa E; Ohtani S
    Jpn J Exp Med; 1975 Oct; 45(5):423-7. PubMed ID: 57253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides.
    Kennedy MK; Tan LJ; Dal Canto MC; Tuohy VK; Lu ZJ; Trotter JL; Miller SD
    J Immunol; 1990 Feb; 144(3):909-15. PubMed ID: 1688591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes.
    Sharma SD; Nag B; Su XM; Green D; Spack E; Clark BR; Sriram S
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11465-9. PubMed ID: 1722335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental allergic encephalomyelitis: clinical disease and enhanced cellular transfer in the absence of lymphocyte proliferative responses against syngeneic MBP.
    Hunter S
    Cell Immunol; 1986 Jan; 97(1):204-9. PubMed ID: 2427218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-specific down-regulation of myelin basic protein-reactive T cells during spontaneous recovery from experimental autoimmune encephalomyelitis: further evidence of apoptotic deletion of autoreactive T cells in the central nervous system.
    Tabi Z; McCombe PA; Pender MP
    Int Immunol; 1995 Jun; 7(6):967-73. PubMed ID: 7577805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid depletion of peripheral antigen-specific T cells in TCR-transgenic mice after oral administration of myelin basic protein.
    Meyer AL; Benson J; Song F; Javed N; Gienapp IE; Goverman J; Brabb TA; Hood L; Whitacre CC
    J Immunol; 2001 May; 166(9):5773-81. PubMed ID: 11313421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
    Chen Y; Inobe J; Kuchroo VK; Baron JL; Janeway CA; Weiner HL
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):388-91. PubMed ID: 8552644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of autoimmune cells proliferating to myelin basic protein and selection of T cell lines that mediate experimental autoimmune encephalomyelitis (EAE) in mice.
    Ben-Nun A; Lando Z
    J Immunol; 1983 Mar; 130(3):1205-9. PubMed ID: 6185574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of myelin lipids in experimental allergic encephalomyelitis. III. Transfer of suppression from guinea pigs recovering from EAE, induced by myelin basic protein--galactocerebroside complexes.
    Hosein ZZ; Gilbert JJ; Strejan GH
    Cell Immunol; 1986 Apr; 99(1):265-78. PubMed ID: 2428529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive dissociation of encephalitogenic complexes between antigen presenting cells and myelin basic protein.
    Gautam AM; Glynn P
    J Neuroimmunol; 1991 Oct; 34(1):25-31. PubMed ID: 1716639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. II. Fine specificity of effector T cell inhibition.
    Tan LJ; Kennedy MK; Miller SD
    J Immunol; 1992 May; 148(9):2748-55. PubMed ID: 1374098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation of relapsing experimental allergic encephalomyelitis.
    Lublin FD
    Neurology; 1984 Dec; 34(12):1615-7. PubMed ID: 6209597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell vaccination prevents EAE effector cell development but does not inhibit priming of MBP responsive cells.
    Bouwer HG; Hinrichs DJ
    J Neurosci Res; 1996 Aug; 45(4):455-62. PubMed ID: 8872906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.